Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine the efficacy and safety in treating patients with
chronic central serous chorioretinopathy with the drug eplerenone.